BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35295856)

  • 1. Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.
    Yu B; Xue X; Yin Z; Cao L; Li M; Huang J
    Front Cell Dev Biol; 2022; 10():844050. PubMed ID: 35295856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy.
    Dhas N; GarcĂ­a MC; Kudarha R; Pandey A; Nikam AN; Gopalan D; Fernandes G; Soman S; Kulkarni S; Seetharam RN; Tiwari R; Wairkar S; Pardeshi C; Mutalik S
    J Control Release; 2022 Jun; 346():71-97. PubMed ID: 35439581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications.
    Guan X; Xing S; Liu Y
    Nanomaterials (Basel); 2024 Feb; 14(5):. PubMed ID: 38470744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
    Tian X; Shi A; Wu J
    Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy.
    Guan Q; Dou H
    Front Physiol; 2021; 12():763085. PubMed ID: 34916956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine.
    Lopes D; Lopes J; Pereira-Silva M; Peixoto D; Rabiee N; Veiga F; Moradi O; Guo ZH; Wang XD; Conde J; Makvandi P; Paiva-Santos AC
    Mil Med Res; 2023 Apr; 10(1):19. PubMed ID: 37101293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.
    Lei W; Yang C; Wu Y; Ru G; He X; Tong X; Wang S
    J Nanobiotechnology; 2022 Jan; 20(1):45. PubMed ID: 35062958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy.
    Li Z; Wang Y; Liu J; Rawding P; Bu J; Hong S; Hu Q
    Adv Mater; 2021 Sep; 33(38):e2102580. PubMed ID: 34347325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in cell membrane camouflage-based biosensing application.
    Yu X; Sha L; Liu Q; Zhao Y; Fang H; Cao Y; Zhao J
    Biosens Bioelectron; 2021 Dec; 194():113623. PubMed ID: 34530371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell membrane-covered nanoparticles as biomaterials.
    Xuan M; Shao J; Li J
    Natl Sci Rev; 2019 May; 6(3):551-561. PubMed ID: 34691904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia.
    Bose RJ; Kim BJ; Arai Y; Han IB; Moon JJ; Paulmurugan R; Park H; Lee SH
    Biomaterials; 2018 Dec; 185():360-370. PubMed ID: 30273835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart Nanocarriers for Targeted Cancer Therapy.
    Martinelli C
    Anticancer Agents Med Chem; 2021; 21(5):546-557. PubMed ID: 32560615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
    Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
    Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatile biomimetic nanomedicine for treating cancer and inflammation disease.
    Zhao Z; Wang D; Li Y
    Med Rev (2021); 2023 Apr; 3(2):123-151. PubMed ID: 37724085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.
    Li R; He Y; Zhang S; Qin J; Wang J
    Acta Pharm Sin B; 2018 Jan; 8(1):14-22. PubMed ID: 29872619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research update on cell membrane camouflaged nanoparticles for cancer therapy.
    Wang C; Wu S
    Front Bioeng Biotechnol; 2022; 10():944518. PubMed ID: 35992357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications.
    Choi B; Park W; Park SB; Rhim WK; Han DK
    Methods; 2020 May; 177():2-14. PubMed ID: 31874237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-derived nanomaterials for biomedical applications.
    Yip LX; Wang J; Xue Y; Xing K; Sevencan C; Ariga K; Leong DT
    Sci Technol Adv Mater; 2024; 25(1):2315013. PubMed ID: 38476511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review.
    He Z; Zhang Y; Feng N
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110298. PubMed ID: 31753336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.